Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

With approval, the company can begin commercializing the device in the U.S. in 2025.

Roivios announced that it received FDA investigational device exemption (IDE) approval to conduct a trial for its renal ...

Andromeda Surgical announced that a surgeon performed a robotic-assisted holmium laser enucleation of the prostate (HoLEP) ...

Dexcom and Fidelity Management & Research Company contributed to the financing. This investment comes as part of a new health ...

Smith+Nephew (NYSE: SNN) announced today that it received FDA clearance for its Coriograph pre-op planning and modeling ...

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.